Impact of a Communication Strategy in the Prevention of Depressive Symptoms in Patients with Covid-19

NCT ID: NCT05035563

Last Updated: 2025-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

350 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-01

Study Completion Date

2022-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the effect of an early and integral communication strategy (EICS) versus standard care, on the rate of depressive symptoms at 3 months after discharge from the ICU, in patients with severe Covid-19, their family members and health personnel.

Evaluating the rate of depressive symptoms at 3 months after discharge from the ICU, with a) Hospital Anxiety and Depression, b) Posttraumatic Stress Disorder Checklist (S)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We designed a pre-post intervention study, the groups were non-randomly allocated.

The study is implementation in 10 Chilean hospitals, admitting 350 patients.

Pre-intervention: The practices of each ICU will be maintained, until the moment that according to randomization corresponds the beginning of the intervention, in each center.

Post-intervention: EICS to facilitate communication between the family, patient and health team, through written material, via the web (tablet and webmaster) and by telephone.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Illness Mechanical Ventilation Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SEQUENTIAL

Pre-intervention: The practices of each ICU will be maintained, until the moment that according to randomization corresponds to the beginning of the intervention, in each center

Post-intervention: Integral and early strategy to facilitate communication between the family, patient and health team. For this it will be implemented written material, via the web (tablet and webmaster) and by telephone.

It also includes strategies to support health teams, weekly multidisciplinary virtual meetings with the family, ICU diaries for family members.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Traditional communication management (Pre-intervention)

Traditional communication practices are maintained, which consists of reporting the patient's medical conditions or specific requirements of the case, between the health team and the family.

According to the social and administrative conditions of each centers, medical telephone information is provided on the conditions of the patients.

Group Type NO_INTERVENTION

No interventions assigned to this group

Early and integral communication strategy (EICS) (Post-intervention)

EICS that includes a bundle of various strategies that allow to favor communication and contact between family members, patients and health team.

That considers the delivery of: (1) Receive timely and understandable information; (2) Receive visits, companionship, and spiritual assistance

Group Type EXPERIMENTAL

Intervention. Early and integral communication strategy (EICS)

Intervention Type BEHAVIORAL

This intervention will be implemented in patients since they are hospitalized in the ICU where is expected:

* Facilitate contact and communication between patients, families and the health team.
* Respond to the communication needs of family members.
* Reduce equipment overload and facilitate communication with families and patients, providing tools and timely support.
* Build a positive and trusting relationship of relatives and patients with health teams.

The intervention considers the following actions:

1. \- Training in communication to the health team
2. \- Written material
3. \- Family website
4. \- Standardized and daily telephone information
5. \- Health Team Support Strategy
6. \- Weekly multidisciplinary virtual meeting with the family
7. \- ICU diaries for family members

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention. Early and integral communication strategy (EICS)

This intervention will be implemented in patients since they are hospitalized in the ICU where is expected:

* Facilitate contact and communication between patients, families and the health team.
* Respond to the communication needs of family members.
* Reduce equipment overload and facilitate communication with families and patients, providing tools and timely support.
* Build a positive and trusting relationship of relatives and patients with health teams.

The intervention considers the following actions:

1. \- Training in communication to the health team
2. \- Written material
3. \- Family website
4. \- Standardized and daily telephone information
5. \- Health Team Support Strategy
6. \- Weekly multidisciplinary virtual meeting with the family
7. \- ICU diaries for family members

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults\> 18 years old
* Admitted to the ICU
* Requiring Mechanical Ventilation\> 12 hrs due to COVID-19

Exclusion Criteria

* Patients with therapeutic proportionality is defined early
* Patients with communication limitations (they do not speak Spanish) are excluded.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Chile

OTHER

Sponsor Role collaborator

Universidad de La Frontera

OTHER

Sponsor Role collaborator

Pontificia Universidad Catolica de Chile

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Leyla Alegria

Role: PRINCIPAL_INVESTIGATOR

Pontificia Universidad Catolica de Chile

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pontificia Universidad Católica de Chile - Medicina

Santiago, Santiago Metropolitan, Chile

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Chile

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

COVID0921

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.